The last several weeks have seen several dramatic mergers of drug companies. Two experts talk about what these changes will mean for the industry, for stockholders, for drug research, and for consumers.

Guests

  • Wayne Pines consultant to the pharmaceutical industry
  • Dr. Sidney Wolfe director of the Health Research Group at Public Citizen; editor of WorstPills.org

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Susan Faludi: “In the Darkroom”

Thursday, Jun 30 2016At age 76, Susan Faludi's father underwent sex reassignment surgery. When Stephen became Stefanie, the feminist writer sets out on a journey to better understand her father -- an exploration that becomes an inquiry into the meaning of identity.

Can We Trust Our Cars?

Thursday, Jun 30 2016There were more airbag recalls this week, and VW has agreed to pay nearly fifteen billion in its emissions cheating scandal. Meanwhile, cars with driverless technology are becoming available, but whether they will make us safer is up for debate. A look at auto safety and consumer trust.